Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Aug 6;13(8):e16945.
doi: 10.7759/cureus.16945. eCollection 2021 Aug.

Posterior Reversible Encephalopathy in Undiagnosed Systemic Lupus Erythematosus: A Rare Case Report

Affiliations
Case Reports

Posterior Reversible Encephalopathy in Undiagnosed Systemic Lupus Erythematosus: A Rare Case Report

Wardah Khalid Rafat et al. Cureus. .

Abstract

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder known to affect the nervous system by direct neuronal damage, vasculitis, or pathologic mechanisms indirectly induced by immune mechanisms related to the production and deposition of immune complexes. SLE has a wide range of clinical manifestations due to the involvement of almost every organ system of the body. SLE presents with serositis, mucositis, arthralgia, glomerulopathy, hematological, cutaneous, and hematological manifestations. Among the neurological manifestations of SLE, posterior reversible encephalopathy is rarely described in the literature. We report a case of posterior reversible encephalopathy in a female patient who presented with seizures, altered mentation, headache, and blurry vision in the setting of undiagnosed SLE.

Keywords: posterior reversible encephalopathy syndrome; pres; seizure; sle; systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Axial images of brain MRI showing patchy areas of hyperintense signals (white arrows) in cortical and subcortical areas of temporal, parietal (a, b), and occipital lobes (c).
MRI: magnetic resonance imaging.

References

    1. Systemic lupus erythematosus: diagnosis and clinical management. Fava A, Petri M. J Autoimmun. 2019;96:1–13. - PMC - PubMed
    1. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. Kampylafka EI, Alexopoulos H, Kosmidis ML, et al. PLoS One. 2013;8:0. - PMC - PubMed
    1. Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study. Merayo-Chalico J, Apodaca E, Barrera-Vargas A, et al. J Neurol Neurosurg Psychiatry. 2016;87:287–294. - PubMed
    1. Clinical features and outcomes of patients with posterior reversible encephalopathy syndrome. Kalaiselvan MS, Renuka MK, Arunkumar AS. Indian J Crit Care Med. 2017;21:453–456. - PMC - PubMed
    1. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Mayo Clin Proc. 2010;85:427–432. - PMC - PubMed

Publication types